ThinkEquity Assumes Optimer Pharma (OPTR) at Buy, Sets $25 Price Target

May 14, 2012 11:04 AM EDT Send to a Friend
Get Alerts OPTR Hot Sheet
Price: $12.78 --0%

Rating Summary:
    4 Buy, 9 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade OPTR Now!
Join SI Premium – FREE
ThinkEquity's James Molloy assumed coverage on Optimer Pharmaceuticals (NASDAQ: OPTR) with a Buy rating and $25 price target Monday morning.

The stock is up about 1.2 percent to $15.22 at last check.

For an analyst ratings summary and ratings history on Optimer Pharmaceuticals click here. For more ratings news on Optimer Pharmaceuticals click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

ThinkEquity

Add Your Comment